Arteris Inc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
AIP$19.09-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Loss
(In thousands, except share and per share data)
| Year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue | ||
| Licensing, support and maintenance | $48,273 | $46,012 |
| Variable royalties and other | 5,393 | 4,366 |
| Total revenue | 53,666 | 50,378 |
| Cost of revenue | 5,077 | 4,281 |
| Gross profit | 48,589 | 46,097 |
| Operating expenses: | ||
| Research and development | 45,128 | 41,167 |
| Sales and marketing | 20,659 | 17,419 |
| General and administrative | 17,944 | 16,367 |
| Total operating expenses | 83,731 | 74,953 |
| Loss from operations | (35,142) | (28,856) |
| Interest expense | (211) | (89) |
| Other income (expense), net | 3,558 | 1,425 |
| Loss before income taxes and loss from equity method investment | (31,795) | (27,520) |
| Loss from equity method investment, net of tax | 3,397 | 284 |
| Provision for (benefit from) income taxes | 1,677 | (417) |
| Net loss | $(36,869) | $(27,387) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.03) | $(0.84) |
| Weighted average shares used in computing per share amounts, basic and diluted | 35,675,689 | 32,578,776 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.